Search

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

Saul Ewing LLP is proud to announce a favorable outcome won on behalf of Firm client Rembrandt Enterprises. Alain Baudry, partner, Tricia Kazinetz, associate, secured a $1.46 million jury verdict on its breach of contract claim following a two-day trial in federal court in Evansville, Indiana. About...